Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

6170 of 114481
Newswise: Study Finds that Psoriasis Onset Determines if Psoriatic Arthritis Patients Develop Arthritis or Psoriasis First
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Study Finds that Psoriasis Onset Determines if Psoriatic Arthritis Patients Develop Arthritis or Psoriasis First

American College of Rheumatology (ACR)

In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis. Additionally, they found that pustular psoriasis is associated with arthritis onset two years earlier than the intercept interval; and there is an increased delay for nail involvement, plaque psoriasis or family history of psoriasis from psoriasis to arthritis by approximately two years for each characteristic.(Abstract #2854).

Channels: Arthritis, Bone Health, Dermatology, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Methotrexate Significantly Reduces Joint Damage Progression Over Placebo in Erosive Hand OA, and May Facilitate Bone Remodeling

American College of Rheumatology (ACR)

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis, but did significantly reduce the progression of joint damage over placebo and seems to facilitate bone remodeling in these patients

Channels: Aging, All Journal News, Arthritis, Bone Health, Clinical Trials, Pharmaceuticals, Seniors, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
Newswise: ADA2 is a Sensitive, Specific Biomarker for Life-Threatening Macrophage Activation Syndrome in Systemic JIA
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

ADA2 is a Sensitive, Specific Biomarker for Life-Threatening Macrophage Activation Syndrome in Systemic JIA

American College of Rheumatology (ACR)

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, adenosine deaminase 2 (ADA2) in the peripheral blood is a sensitive, specific biomarker for macrophage activation syndrome, a potentially life-threatening complication of systemic juvenile idiopathic arthritis (systemic JIA)

Channels: All Journal News, Arthritis, Bone Health, Children's Health, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
Newswise: For People with OA, Opioids Offer Minor Pain Relief and Function Benefits, but No Quality of Life Benefit
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

For People with OA, Opioids Offer Minor Pain Relief and Function Benefits, but No Quality of Life Benefit

American College of Rheumatology (ACR)

New research presented at the 2019 ACR/ARP Annual Meeting suggests that opioids contribute no measurable benefit to quality of life or depression for patients with osteoarthritis (OA).

Channels: Aging, Arthritis, Bone Health, Drugs and Drug Abuse, Pain, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Physicians Should Consider Hydroxychloroquine to Reduce the Risk of Recurrent Congenital Heart Block in Subsequent Pregnancies of Women with Anti-SSA/Ro Antibodies

American College of Rheumatology (ACR)

New research findings presented at the 2019 ACR/ARP Annual Meeting discovered that hydroxychloroquine (HCQ) significantly reduces the recurrence rate of congenital heart block in subsequent pregnancies of women with anti-SSA/ Ro antibodies, regardless of their health status.

Channels: Autoimmune Diseases, Cardiovascular Health, Immunology, Liver Disease, Neuro, Children's Health, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Live Zoster Vaccine Safe and Effective for People Taking TNF Inhibitors

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, the live zoster virus vaccine is safe for people who are currently receiving tumor necrosis factor inhibitor (TNFi) biologic therapies for various indications.

Channels: Arthritis, Autoimmune Diseases, Bone Health, Vaccines, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
Newswise: Biologics Offer Similar Disease Activity Improvement for Both Elderly-Onset and Young-Onset RA Patients
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Biologics Offer Similar Disease Activity Improvement for Both Elderly-Onset and Young-Onset RA Patients

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

Channels: Aging, Arthritis, Bone Health, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Half of People with RA Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment

American College of Rheumatology (ACR)

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

Channels: Arthritis, Autoimmune Diseases, Cancer, Immunology, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
Newswise: Children with Down Syndrome at Increased Risk for Associated Inflammatory, Erosive Arthritis
  • Embargo expired:
    9-Nov-2019 4:30 PM EST
Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results
Newswise: Post-Market Price Changes Alone Account for Most Recent Spending Growth for Biologics, and Rebates Have Little Impact
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Post-Market Price Changes Alone Account for Most Recent Spending Growth for Biologics, and Rebates Have Little Impact

American College of Rheumatology (ACR)

New research findings presented at the 2019 ACR/ARP Annual Meeting found that annual spending on biologic DMARDS (biologics) by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016.

Channels: All Journal News, Healthcare, Pharmaceuticals, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Open in New Tab
Comment
Research Results

Showing results

6170 of 114481

Chat now!
6.15152